Recombinant HAV VP1-P2A Protein (aa 669-782) (VAng-Lsx0165)
HAV VP1-P2A (aa 669-782), recombinant protein from E. coli.
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
10mM Tris-HCl, pH 9.6, 1.5M urea, 50 % glycerol.
Purity
> 90 % pure by 10 % SDS-PAGE.
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Introduction
The Hepatitis A virus (HAV), or Hepatovirus A, is a virus of the Picornaviridae family. It takes human and vertebrates as its natural hosts. HAV isolates all belong to a single serotype, seven genetic groups now have been defined, four for humans (genotype number: I-III, and VII) and three for simian (genotype number: IV-VI). Hepatitis A is an infectious disease of the liver caused by the hepatitis A virus. HAV achieves about 1.4 million worldwide symptomatic cases per year and is the cause of Hepatitis A (formerly known as infectious hepatitis, an acute infectious disease of the liver). It is usually spread by eating food or drinking water contaminated with infected feces.
Alternative Names
HAV P2C-P3A; Hepatitis A VP1-P2A
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.